X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/09/2859836/0/en/Artios-Pharma-Bolsters-Board-of-Directors-with-Appointment-of-Chris-Liu-PhD.html
https://www.globenewswire.com//news-release/2023/10/05/2755338/0/en/Artios-to-Present-Initial-Phase-1-Clinical-Monotherapy-Data-for-ATR-Inhibitor-ART0380-in-Advanced-Solid-Tumors-at-the-European-Society-of-Medical-Oncology-Congress-2023.html
https://www.globenewswire.com/news-release/2023/02/09/2604927/0/en/Artios-Announces-Initiation-of-Phase-2-Randomized-Trial-for-ATR-Inhibitor-ART0380-plus-Gemcitabine-in-Patients-with-Platinum-Resistant-Ovarian-Cancer.html
https://www.globenewswire.com/news-release/2022/08/10/2495490/0/en/Artios-initiates-Phase-2-study-of-Pol%CE%B8-Inhibitor-ART4215-in-Combination-with-PARP-Inhibitor-Talazoparib-in-BRCA-Deficient-Breast-Cancer.html
https://www.globenewswire.com/news-release/2022/06/23/2467911/0/en/Artios-Appoints-Samantha-Truex-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2022/04/05/2416232/0/en/Artios-Announces-ATR-Inhibitor-ART0380-Development-On-Track-and-Progressing-Into-Phase-1b-Evaluation.html
https://www.fiercebiotech.com/biotech/artios-raises-153m-to-fund-dna-damage-repair-clinical-trials
https://www.fiercebiotech.com/biotech/artios-raises-153m-to-fund-dna-damage-repair-clinical-trials
https://www.globenewswire.com/news-release/2021/06/17/2249163/0/en/Artios-Pharma-Publishes-Preclinical-Data-on-The-First-Selective-Small-Molecule-Pol%CE%B8-Polymerase-Inhibitor-in-Nature-Communications.html
https://www.genengnews.com/news/novartis-artios-pharma-target-cancer-in-up-to-1-3b-ddr-collaboration/
Market Place
Share 
